









Märkte
/
Aktien
/
nasdaq-gkos
/

Glaukos Corp

GKOS

112.520USD

-0.990-0.87%

Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert

6.46BMarktkapitalisierung

VerlustKGV TTM



Glaukos Corp

112.520

-0.990-0.87%

Übersicht Finanzen Analyse Unternehmen

Übersicht

Finanzen

Analyse

Unternehmen

mehr Informationen über Glaukos Corp Unternehmen

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Glaukos Corp Informationen



BörsenkürzelGKOS

Name des UnternehmensGlaukos Corp

IPO-datumJun 25, 2015

CEOBurns (Thomas William)

Anzahl der mitarbeiter995

WertpapierartOrdinary Share

GeschäftsjahresendeJun 25

Addresse1 Glaukos Way

StadtALISO VIEJO

BörseNASDAQ OMX NASDAQ Basic NYSE

LandUnited States of America

Postleitzahl92656

Telefon19493679600

Websitehttps://www.glaukos.com

BörsenkürzelGKOS

IPO-datumJun 25, 2015

CEOBurns (Thomas William)

Führungskräfte von Glaukos Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

Mr. David F. Hoffmeister

Independent Director

70.27K

+753.00%

Mr. Mark J. Foley

Lead Independent Director

57.52K

+1168.00%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.85K

+623.00%

Mr. Marc A. Stapley

Independent Director

36.91K

+727.00%

Dr. Tomas Navratil

Chief Development Officer

34.86K

+1544.00%

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

Mr. Joseph E. Gilliam

President, Chief Operating Officer

Dr. Leana S. Wen, M.D.

Independent Director

Ms. Denice M. Torres, J.D.

Independent Director

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

Mr. David F. Hoffmeister

Independent Director

70.27K

+753.00%

Mr. Mark J. Foley

Lead Independent Director

57.52K

+1168.00%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.85K

+623.00%

Mr. Marc A. Stapley

Independent Director

36.91K

+727.00%

Dr. Tomas Navratil

Chief Development Officer

34.86K

+1544.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Glaucoma

110.25M

82.56%

Corneal Health

23.29M

17.44%

Nach RegionUSD

Name

Umsatz

Anteil

United States

101.45M

75.97%

International

32.09M

24.03%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Glaucoma

110.25M

82.56%

Corneal Health

23.29M

17.44%

Aktionärsstatistik

Aktualisiert: Sat, Jan 31

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.46%

Wellington Management Company, LLP

6.23%

PRIMECAP Management Company

3.92%

State Street Investment Management (US)

3.66%

Andere

62.13%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.46%

Wellington Management Company, LLP

6.23%

PRIMECAP Management Company

3.92%

State Street Investment Management (US)

3.66%

Andere

62.13%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

48.90%

Investment Advisor/Hedge Fund

35.43%

Hedge Fund

10.15%

Individual Investor

3.31%

Research Firm

2.10%

Pension Fund

2.05%

Sovereign Wealth Fund

1.32%

Bank and Trust

0.92%

Venture Capital

0.64%

Institutionelle Beteiligung



Aktualisiert: Thu, Jan 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

678

58.37M

101.63%

-6.67M

2025Q3

653

61.34M

106.80%

+235.97K

2025Q2

638

61.06M

106.48%

+15.37K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

7.81M

13.59%

-89.56K

-1.13%

Sep 30, 2025

The Vanguard Group, Inc.

6.03M

10.5%

-65.70K

-1.08%

Sep 30, 2025

Wellington Management Company, LLP

3.58M

6.23%

+336.27K

+10.36%

Sep 30, 2025

PRIMECAP Management Company

2.25M

3.92%

+425.79K

+23.29%

Sep 30, 2025

State Street Investment Management (US)

2.10M

3.66%

+14.00K

+0.67%

Sep 30, 2025

AllianceBernstein L.P.

1.73M

3.02%

+481.62K

+38.47%

Sep 30, 2025

Burns (Thomas William)

1.51M

2.63%

+3.07K

+0.20%

Dec 30, 2025

Geode Capital Management, L.L.C.

1.32M

2.29%

-14.51K

-1.09%

Sep 30, 2025

Columbia Threadneedle Investments (US)

1.27M

2.21%

+247.45K

+24.25%

Sep 30, 2025

Westfield Capital Management Company, L.P.

1.23M

2.14%

+63.79K

+5.46%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

Invesco S&P SmallCap Health Care ETF

3.09%

Alger Weatherbie Enduring Growth ETF

2.07%

State Street SPDR S&P Health Care Equipment ETF

1.79%

ROBO Global Healthcare Technology & Innovation ETF

1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.65%

iShares S&P Small-Cap 600 Growth ETF

0.64%

iShares U.S. Medical Devices ETF

0.6%

OneAscent Enhanced Small and Mid Cap ETF

0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

0.51%

Invesco S&P SmallCap Health Care ETF

Anteil3.09%

Alger Weatherbie Enduring Growth ETF

Anteil2.07%

State Street SPDR S&P Health Care Equipment ETF

Anteil1.79%

ROBO Global Healthcare Technology & Innovation ETF

Anteil1.4%

State Street SPDR S&P 600 Small Cap Growth ETF

Anteil0.69%

Vanguard S&P Small-Cap 600 Growth Index Fund

Anteil0.65%

iShares S&P Small-Cap 600 Growth ETF

Anteil0.64%

iShares U.S. Medical Devices ETF

Anteil0.6%

OneAscent Enhanced Small and Mid Cap ETF

Anteil0.53%

State Street SPDR S&P SmallCap 600 ESG ETF

Anteil0.51%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

KeyAI

